CHAPTER 7 REFERENCES

ACOG Committee Opinion Number 823, March 2021. Health Care for Transgender and Gender Diverse Individuals. https://bit.ly/35VjHVN.

Ali M, Bahamondes L, Bent Landoulsi S. Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. FDA Product Labeling. Glob Health Sci Pract. 2017 Dec28;5(4):534-539. https://bit.ly/3docVWJ

Amico JR, Bennett AH, Karasz A, et al. Taking the provider “out of the loop:” patients’ and physicians’ perspectives about IUD self-removal. Contraception. 2018 Oct;98(4):288-291. https://bit.ly/2KPbft6

ASEC Factsheet: Providing Ongoing Hormonal Contraception after Use of Emergency Contraceptive Pills, Sep 2016. https://bit.ly/35kYDmS

Bahamondes MV, Espejo-Arce X, Bahamondes L. Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT. Hum Reprod. 2015 Aug;30(8):1861-6.  https://bit.ly/2VSBSUd

BakenRa A, Gero A, Sanders J, Simmons R, Fay K, Turok DK. Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception. Obstet Gynecol. 2021 Jul 1;138(1):79-84. https://bit.ly/3LUll9b

Becker D, Tsui AO. Reproductive health service preferences and perceptions of quality among low-Income women. Perspectives on Sexual and Reproductive Health, 2008, 40(4) https://bit.ly/2YrDoyt

Birgisson NE, Zhao Q, Secura GM, et al. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review. J Womens Health (Larchmt). 2015;24(5):349. https://bit.ly/2WcbxPX

Bonnington A, Dianat S, Kerns J, et al. Society of Family Planning clinical recommendations: Contraceptive counseling for transgender and gender diverse people who were assigned female sex at birth. Contraception. April 2020. https://bit.ly/3exiL8I

Boudreau D, Mukerjee R. Contraception Care for Transmasculine individuals on testosterone therapy. Journal of Midwifery & Women’s Health. July/August 2019. 64(4): 395-402. https://bit.ly/2KPpDRS

Brandi K, Woodhams E, White KO, et al. An exploration of perceived contraceptive coercion at the time of abortion. Contraception. 2018;97(4):329‐334. https://bit.ly/2X2BXFu

Burlando AM, Flynn AN, Gutman S, et al. The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic. Obstet Gynecol. 2021;138(4):574-577. https://bit.ly/3tWOc5t

Centers for Disease Control. Providing Quality Family Planning Services: Recommendations of CDC and the U.S. Office of Population Affairs April 25, 2014 / 63(RR04); 1-29. https://bit.ly/2Wb41ox

Centers for Disease Control. United States Selected Practice Recommendations for Contraceptive Use, 2016. MMWR, 2016 https://bit.ly/3bQbxeY

Centers for Disease Control. United States Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Early Release, 2016 https://bit.ly/2VQC6v7

Davies A, Fleming C. Do intrauterine device/intrauterine system users check their threads? J Fam Plann Reprod Health Care. 2014 Apr;40(2):122-5. https://bit.ly/35q9hJ1

Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014 Dec;57(4):659-73. https://bit.ly/3aT0Rer

Dehlendorf C, Henderson JT, Vittinghoff E, et al. Development of a patient-reported measure of the interpersonal quality of family planning care. Contraception. 2018 Jan;97(1):34-40. https://bit.ly/2ySK5i9

Diedrich JT, Zhao Q, Madden T, Secura GM, Peipert JF. Three-year continuation of reversible contraception. Am J Obstet Gynecol. 2015 Nov;213(5):662.e1-8. https://bit.ly/3aT2bxV

Edelman A. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Syst Rev. 2014 Jul 29;2014(7):CD004695. https://bit.ly/2Yz9nwB

Endler M, Li R, Gemzell Danielsson K. Effect of levonorgestrel emergency contraception on implantation and fertility: A review. Contraception. 2022 May;109:8-18. https://bit.ly/3PJBscC

Fay KE, Clement AC, Gero A, Kaiser JE, Sanders JN, BakenRa AA, Turok DK. Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations. Contraception. 2021 Nov;104(5):561-566. https://bit.ly/3GARJMP

Foster DG, Parvataneni R, de Bocanegra HT, Lewis C, Bradsberry M, Darney P. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet Gynecol. 2006 Nov;108(5):1107-14. http://goo.gl/jLmVF

Foster DG, Grossman D, Turok DK, et al. Interest in and experience with IUD self-removal. Contraception. 2014 Jul;90(1):54-9. https://bit.ly/2yTGzUS

Gavin L. Update: Providing Quality Family Planning Services — Recommendations from CDC and the U.S. Office of Population Affairs, 2017. MMWR Morb Mortal Wkly Rep. 2017;66. https://bit.ly/3KAC5lo

Glasier A, Cameron ST, Blithe D et al. Can we identify women at risk of pregnancy despite using emergency contraception? Contraception 2011; 84:363–367. https://bit.ly/3fcCwDR

Grossman D. Routine follow-up visits after first trimester induced abortion.  Obstet Gynecol.  2004 April:  103(4): 738-745.  https://bit.ly/3aT3lcL

Guttmacher Institute. Reasons for Unmet Need for Contraception in Developing Countries. June 2016. https://bit.ly/2VU03lj

Hubacher D, Lara-Ricalde R, Taylor DJ, et al.Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. New England Journal of Medicine. 2001;345,561-7. https://bit.ly/2xjN0jo

Krempasky C, Harris M, Abern L, et al. Contraception across the transmasculine spectrum. American Journal of Obstetrics and Gynecology. 2020 Feb;222(2):134-143. https://bit.ly/2VOcA9E

London A, Jensen JT. Rationale for eliminating the hormone-free interval in modern oral contraceptives. Int J Gynaecol Obstet. 2016 Mar 20. pii: S0020-7292(16)30040-6.  https://bit.ly/3aXXV0d

Lopez LM, Bernholc A, Chen M, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database of Systematic Reviews 2016, Issue 8. Art. No.: CD008452. https://bit.ly/2XXarbA

Matulich M, Cansino C, Culwell KR, et al. Understanding women’s desires for contraceptive counseling at the time of first-trimester surgical abortion.Contraception. 2014 Jan;89(1):36-41.  https://bit.ly/3ey1dt7

Mody SK, Farala JP, Jimenez B, et al. Paracervical Block for IUD Placement Among Nulliparous Women: A Randomized Controlled Trial. Obstet Gynecol. 2018;132(3):575‐582. https://bit.ly/36VGWez

Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception. 2007 Jun;75(6 Suppl):S16-30. https://bit.ly/3x0yYhq

Raifman S, Barar R, Foster D. Effect of Knowledge of Self-removability of IUCs on Uptake, Continuation, and Satisfaction. Womens Health Issues. 2018 Jan – Feb;28(1):68-74. https://bit.ly/2YhkSZv

Raymond EG, Weaver MA, Louie KS, et al. Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2016;128(4):739‐745. https://bit.ly/308dW1P

Raymond EG, Weaver MA, Tan YL, et al. Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2016;127(2):306‐312. https://bit.ly/3ctKDcu

Sistersong / National Women’s Health Network. LARC Statement Of Principles. Published April 10, 2021. https://bit.ly/36cQt4r

SFP ACOG Practice bulletin no. 143: medical management of first-trimester abortion. Obstet Gynecol. 2014;123(3):676-692. https://bit.ly/2YOWLjv

Shen J, Che Y, Showell E, Chen K, Cheng L. Interventions for emergency contraception.Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD001324. https://bit.ly/3ddSg7w

Sufrin CB, Averbach SH. Testing for sexually transmitted infections at intrauterine device insertion: an evidence-based approach. Clin Obstet Gynecol. 2014 Dec;57(4):682-93. https://bit.ly/2z1JMkY

Ti AJ, Roe AH, Whitehouse KC, Smith RA, Gaffield ME, Curtis KM. Effectiveness and safety of extending intrauterine device duration: a systematic review. Am J Obstet Gynecol. 2020 Jan 15. https://pubmed.ncbi.nlm.nih.gov/31954154/

Turok DK, Gero A, Simmons RG, et al. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception. N Engl J Med 2021; 384:335-344. https://bit.ly/3MMAvyR

Turok DK, Jacobson JC, Dermish AI, et al. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates. Contraception 2014; 89(3): 222-8. https://bit.ly/35Hmulo

Turok DK.  UpToDate: Emergency Contraception, 2022. https://bit.ly/3GMiPRv

United Nations Population Division | Department of Economic and Social Affairs. https://bit.ly/2yen3Cq

Wu S, Godfrey EM, Wojdyla D, et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010;117:1205–1210. https://bit.ly/2SpqBbP

Yee LM, Simon MA. Perceptions of Coercion, Discrimination, and other Negative Experiences in Post-Partum Contraceptive Counseling for Low-Income Minority Women. J of Health Care for the Poor and Underserved. 22;4;2011. https://bit.ly/2KOMtZW